3rd Partners Meeting on Better Medicines for Children. Update Ecumenical Pharmaceutical Network / EPN

Similar documents
THE UNITED REPUBLIC OF TANZANIA MINISTRY OF HEALTH AND SOCIAL WELFARE. June-July 2008

THE UNITED REPUBLIC OF TANZANIA MINISTRY OF HEALTH AND SOCIAL WELFARE. June-July 2007

THE UNITED REPUBLIC OF TANZANIA MINISTRY OF HEALTH AND SOCIAL WELFARE. Nov Dec 2006

21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review

PRODUCTS LIST INFECTIOLOGY

International Journal of Pharmacy

INJECTION GMP FSC AMPICILLIN SODIUM 500mg/1 g+ SULBACTAM DRY POWDER INJECTION GMP FSC

Rate In Rs.Ps (ED Included. Tax Extra) Sl No Name Of The Product Pack. Scheduled And Non-Scheduled Formulations Capsules

QUALITY HEALTH CARE YOUR PREFERRED PARTNER IN. For better health

Medicine Price Monitor

YOUR COMPLETE SOURCE FOR MEDICAL MISSIONS SUPPLIES.

Chart showing the average height of males and females in various world countries.

YOUR COMPLETE SOURCE FOR MEDICAL MISSIONS SUPPLIES.

ANTIBIOTICS. Orbit s ANTIBIOTICS. Portfolio

I am writing in response to your request for information made under the Freedom of Information Act 2000 in relation to Antibiotics.

Veterinary Education in Africa

GARP ACTIVITIES IN KENYA. Sam Kariuki and Cara Winters

A Professional Certificate in Global Animal Health an opportunity to combine one health training with traditional veterinary education

- the details, where possible, of the antibiotic products these companies supply or have supplied.

National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults

AMOXICILLIN AND CLAVULANIC ACID TABLETS Draft proposal for The International Pharmacopoeia (February 2018)

International Journal of Pharma and Bio Sciences V1(1)2010

Technical updates of the guidelines on Integrated Management of Childhood Illness (IMCI)

European Surveillance of Veterinary Antimicrobial Consumption (ESVAC)

3 party manufacturing PRODUCT LIST. Category : ANTI BIOTIC

One Health tripartite initiatives Updates from WHO perspective to address zoonoses and AMR issues

GLOBAL ANTIBIOTIC RESEARCH & DEVELOPMENT PARTNERSHIP

International Journal of Advances in Pharmacy and Biotechnology Vol.3, Issue-2, 2017, 1-7 Research Article Open Access.

National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults

UNDERSTANDING SOUTH AFRICA'S CONSUMPTION OF ANTIMICROBIALS

Appendix C: Religious restrictions index scores by region

Pew forum on religion & public life

Lyme disease: diagnosis and management

WHO Guideline for Management of Possible Serious Bacterial Infection (PSBI) in neonates and young infants where referral is not feasible


Quality of 2 nd line medicines for tuberculosis. Ms Lisa Hedman World Health Organization Department of Essential Medicines and Health Products

AMR in AFRICA. Dr Marc Sprenger Director AMR Secretariat. Antimicrobial resistance in Africa

Remember: AIEs are painful: analgesics should be prescribed regularly and p.r.n. palliativedrugs.com November/December newsletter

Prescribing Guidelines for Outpatient Antimicrobials in Otherwise Healthy Children

Amoxicillin Mg Dosage

Mutual Recognition of Immunological Veterinary Products in East Africa. NOEL AINEPLAN National Drug Authority Uganda

MEASURING ANTIBIOTIC USE IN LTCFS

Management of Malaria in Children : Update 2008

20mL, 50mL, 100mL. 20mL, 50mL, 100mL. 20mL, 50mL, 100mL. 20mL, 50mL, 100mL. 20mL, 50mL, 100mL. 50mL, 100mL. 50mL, 100mL.

Diarrheal Illness and Childhood Mortality: Filling Up the Half-Empty Glass. Eric Mintz, MD, MPH

Rational management of community acquired infections

WHO Global Surveillance and Monitoring System SSFFC Medical Products (Substandard, Spurious, Falsely labelled, Falsified and Counterfeit)

Martha Nzisa Mutiso, Author Keith L. Bildstein, Corinne Kendall, and Munir Virani, Editors Wendy Frew, Graphic Designer and Illustrator

Community Acquired Pneumonia: An Update on Guidelines

Involvement of Europe in the Global Strategies and Coordination with other regions

Review of requirements and processes for registration of veterinary products in selected African and Asian countries

CENTRE FOR TICKS AND TICK-BORNE DISEASES

BIORISK: AFRICAN EXPERIENCE

The OIE-PVS: a tool for good Governance of Veterinary Services

Introduction. Antimicrobial Usage ESPAUR 2014 Previous data validation Quality Premiums Draft tool CDDFT Experience.

Routine internal quality control as recommended by EUCAST Version 3.1, valid from

AMR Industry Alliance Antibiotic Discharge Targets

Use of oral Cotrimoxazole and injectable Gentamicin in module 6 & 7 of ASHA program

Section 6.2 Antibacterials including Access, Watch and Reserve Lists of antibiotics

ANTIMICROBIAL RESISTANCE IN KENYA; What Surveillance tells us

Dr. Gérard Moulin Anses/ANMV OIE Collaborating Centre on Veterinary medicinal products BP FOUGERES CEDEX, FRANCE

International Health and Medicine, Graduate School of Tokyo Medical and Dental University, Yushima, Bunkyo-ku Tokyo, Japan

Amoxicillin clavulanic acid spectrum

Medicines Medikamente Medicamentos Médicaments

Cancun (México), Nov. 2008

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing

Ciprofloxacin and azithromycin resistance of Campylobacter spp isolated from international travellers,

Bulletin #33. Manitoba Drug Benefits and Interchangeability Formulary Amendments.

Freedom of Information Act 2000 Request Reference FoI/16/226 Companies Supplying Antibiotics

MESSAGE TELECOMMUNICATIONS SERVICE


EUCAST recommended strains for internal quality control

Global Alliance for Rabies Control Annual Report. January to December 2017

Global response to antibiotic access and resistance: Stuart B. Levy, M.D. Tufts University School of Medicine Alliance for Prudent Use of Antibiotics

SILAB For Africa a LIMS for African Country and Animal Identification Registration Traceability system

Emerging Infections and the Ecotone. Cover: Emerging Zoonoses and Pathogens of Public Health Concern

Introduction SEAVDRAC. 23 October Prof G E Swan. Southern and Eastern African Veterinary Drug Regulatory Affairs conference

Action on Antibiotic Resistance (ReAct) Africa Annual Conference 2017

Amoxicillin 500 teva. Call or

Suggested treatment. Inj Crystalline Penicillin 50,000U/Kg i.v. 4-6hrly (if child cannot swallow) 40mg/Kg/dose BID x 10days

Registered Drug Product List:

Study of First Line Antibiotics in Lower Respiratory Tract Infections in Children

Antibiotic Usage Guidelines in Hospital

Presenter: Ombeva Malande. Red Cross Children's Hospital Paed ID /University of Cape Town Friday 6 November 2015: Session:- Paediatric ID Update

Maan Medex Private Limited

Measure Information Form

Guidelines for the Initiation of Empirical Antibiotic therapy in Respiratory Disease (Adults)

ASSESSMENT OF COMMONLY AVAILABLE ANTIMICROBIAL AGENTS. A STUDY FROM ILALA-TANZANIA.

Perichondritis: Source: UpToDate Ciprofloxacin 10 mg/kg/dose PO (max 500 mg/dose) BID Inpatient: Ceftazidime 50 mg/kg/dose q8 hours IV

MEASURING ANTIBIOTIC USE IN LTCFS

MEDICAL SPECIALITIES A.CARDIOVASCULAR INFECTIONS

First-year experiences in implementing Thailand s National Strategic Plan on AMR

CONCORD DRUGS LIMITED Hyderabad

Streptococcus pneumoniae. Oxacillin 1 µg as screen for beta-lactam resistance

Geevet Remedies.

Effective Vaccine Management (EVM) Global Data Analysis

GENERAL NOTES: 2016 site of infection type of organism location of the patient

Antimicrobial Update. Alison MacDonald Area Antimicrobial Pharmacist NHS Highland April 2018

Pharmaceutical issues relating to STI s. June Minton Lead HIV/GUM & Infectious Diseases Pharmacist University College London Hospitals NHS Trust

CIMTRADZ. Capacity building in Integrated Management of Trans-boundary Animal Diseases and Zoonoses

Transcription:

3rd Partners Meeting on Better Medicines for Children Update Ecumenical Pharmaceutical Network / EPN Albert Petersen Difäm - Tübingen EPN board chair November 2011

BOOK-PROJECT

Altogether: 1204 Hospitals 16 Countries 2088 times 3 books Hospitals schools etc 1 Cameroon CBC 30 15 2 Chad Koyom 8 3 Ethiopia ECS 20 4 Ghana CHAG 49 5 Kenya MEDS 140 20 6 Liberia CHAL 12 7 Malawi CHAM 56 8 Namibia CHS 12 9 Nigeria CHAN Medi 70 10 Sierra Leone CHASL 25 11 South-Africa St. Mary Hospital 1 12 Tanzania MEMS 95 100 Tanzania medeor 4 14 13 Uganda UPMB 89 14 Zambia CHAZ 43 15 Zimbabwe ZACH 111 16 India CMAI ( 439)

EPN Surveys: Access to CM in Health Facilities Kenya / Uganda / Chad / Ghana (more to follow if funds available)

Multi-country study on availability and pricing of selected childrens medicines in FBO-Drug Supply Organisations

Participating 12 DSOs Abbreviation Name Country BUFMAR Bureau des Formations Médicales Agréés du Rwanda Rwanda CBC Cameroon Baptist Convention Cameroon CDC Catholic Drug Centre Ghana CDMU Community Development Medical Unit India CHAM Christian Health Association of Malawi Malawi CHAN Christian Health Association Nigeria Nigeria CHAZ Christian Health Association Zambia Zambia JMS Joint Medical Store Uganda MEDS Mission of Essential Drugs and Supplies Kenya MEMS Mission for Essential Medical Supplies Tanzania PEK Pharmacie Evangélique de Koyom Chad PCC Presbyterian Church in Cameroon Cameroon

Differences between12 DSOs Pharmac. trained staff: from 1 to 26 Price list based on NML 11 (12) Medicine offered from 43 to 412 Customers from 25 to 2000 Exporting 3 (12) Value of medicines from 88.000 2010 to 13.000.000

18 key medicines 30 dosage forms Core WHO EMLc 2011 Available? - in line with National Medicine List? -Standard Treatment Guidelines? Price?

Challange: Lists / Guidelines outdated Country National Medicine List Standard Treatment Guideline Cameroon 2001? Chad 2004? Ghana 2010 2010 India 2011? Kenya 2009 2002 Malawi 2009 2009 Nigeria 2003 2008 Rwanda 2010 2007 Tanzania 2007 2007 Uganda 2007 2010 Zambia -?

Availability accoring EMLc 2011 Country DSO Theoretically Theoretically Classification available available [%] Cameroon CBC 15 83,33 High Cameroon PCC 17 94,44 High Chad PEK 10 55,56 Fairly high Ghana CDC 10 55,56 Fairly high India CDMU 11 61,11 Fairly high Kenya MEDS 16 88,89 high Malawi CHAM 8 44,44 Low Nigeria CHAN 12 66,67 Fairly high Rwanda BUFMAR 11 61,11 Fairly high Tanzania MEMS 12 66,67 Fairly high Uganda JMS 18 100,00 high average 12,73 70,71

Availability accoring present NEML Country DSO Theoretically available % Classification Cameroon CBC 10 (11) 91,00 High Cameroon PCC 11 (11) 100,00 High Chad PEK 8 (10) 80,00 Fairly high Ghana CDC 12 (15) 80,00 Fairly high India CDMU 12 (16) 75,00 Fairly high Kenya MEDS 14 (16) 88,00 high Malawi CHAM 10 (14) 71,00 Fairly high Nigeria CHAN 9 (12) 75,00 Fairly high Rwanda BUFMAR 9 (13) 69,00 Fairly high Tanzania MEMS 12 (14) 86,00 High Uganda JMS 15 (15) 100,00 High total 83,18

Availability acc. WHO-EML and NML

Treatment possible according IMCI guidelines? Diarrhoea Country DSO ORS Zinc sulphate Treatment possible? Cameroon CBC - No Cameroon PCC - No Chad PEK Yes Integrated Management of Childhood Illness Ghana CDC - No India CDMU - No Kenya MEDS Yes Malawi CHAM - No Nigeria CHAN - No Rwanda BUFMAR - No Tanzania MEMS - No Uganda JMS Yes Total 11 3 3

Treatment possible according IMCI guidelines? Pneumonia Country DSO Cotrimoxaz ol Ampicillin Gentamicin Ceftriaxone Treatment possible? Cameroon CBC Yes Cameroon PCC Yes Chad PEK Yes Ghana CDC - No India CDMU Yes Kenya MEDS - No Malawi CHAM Yes Nigeria CHAN - - No Rwanda BUFMAR - No Tanzania MEMS Yes Uganda JMS Yes Total 9 9 11 10 7

Treatment possible according National Guidelines? Pneumonia Ghana 2010 Kenya 2009 Rwanda 2007 Uganda 2010 Tanzania 2007 Malawi 2009 Nigeria 2008 Amoxicillin < 2 month: Penicillin+Gentam icin Amoxicillin Cotrimoxazol Cotrimoxazol Amoxicillin Amoxiclav Treatment possible possible possible possible possible possible possible

High availability Offered by all DSOs Amoxicillin oral liquid 125mg/5ml//50mg/5ml Amoxicillin solid oral dosage form 250mg/500mg Oral Rehydration Salt Gentamicin Injection 10mg/20mg/40mg/80mg

High availability Offered by 9/11 DSOs Ciprofloxacin tablets 500mg Cotrimoxazol tablets 120mg/480mg Ampicillin powder for injection 500mg/1g Benzylpenicillin powder for injection 600mg/3g Ceftriaxone powder for injection 250mg/500mg/1g Phenoxymethylpenicillin tablets 250mg

Fairly High availability Amoxicillin + Clavulanic acid tablets 375mg/625mg 6/11DSOs Procainbenzylpenicillin powder for Injection 1g/3g 6/11 DSOs Cotrimoxazol oral liquid 240mg/5ml 8/11 DSOs Artemether Oily Injection 40mg/80mg//ml 6/11 DSOs Artemether + Lumefantrine 20mg + 120mg tablets 7/11 DSOs Doxycycline caps/tabs 100mg 7/11 DSOs Sulfadoxine + Pyrimethamine tablets 500mg+25mg 8/11 DSOs

Low availability Amoxicillin + Clavulanic Acid oral liquid various dasoages > 4/11 DSOs Ciprofloxacin solution for IV infusion2mg/ml 4/11 DSOs Artemether + Lumefantrine dispersible tablets 20mg+120mg 4/11 DSOs

Low availability Artesunate Injection 1/11 DSOs Artesunate rectal dosage form 1/11 DSOs Artemisinin combination tabs 4/11 DSOs Zinc sulphate tablets 20mg 3/11 DSOs

MSH median price per unit in 2010 BUFMAR CBC CDMU MEDS MEMS JMS CDC CHAM CHAN PEK median ratio per medicines Ratio of the DSO price to MSH median price Generic name/dosage Amoxicillin 125mg/5ml Sus Amoxicillin 250mg tab Amoxicillin 500mg tab Ampicillin 1000mg Injection Ceftriaxone 1000mg Injection Ciprofloxacine 500mg tab Cotrimoxazol 240mg/5ml Sus Cotrimoxazol 480mg tab ORS 1l Phenoxymethylpenicillin 250mg tab Doxycyclin 100mg cap 0,003 1,848 2,394 0,758 0,667 0,879 0,727 1,212 1,242 1,182 17,727 0,014 1,007 1,589 3,794 0,667 1,184 0,539 0,872 1,383 1,596 0,024 0,602 1,906 3,893 0,770 1,873 1,176 1,344 0,128 1,255 2,267 1,697 0,835 1,653 0,292 5,438 1,329 1,780 0,993 3,340 1,635 8,769 2,611 0,024 1,295 5,068 3,924 0,907 0,755 0,523 2,025 3,540 1,806 0,002 2,286 4,143 1,000 1,381 0,905 1,000 1,952 2,000 2,476 0,007 1,056 1,549 1,338 0,803 0,972 0,831 1,408 1,127 0,887 1,521 0,035 2,740 3,571 5,949 2,103 0,903 1,786 1,737 3,229 9,383 0,011 1,252 2,937 0,739 0,946 0,784 1,180 1,423 1,577 0,010 0,865 2,663 1,288 0,712 0,923 0,721 0,673 1,212 1,197 1,184 1,344 1,653 2,196 1,806 1,952 1,092 2,740 1,216 0,894 Max. 2,740 5,438 5,949 1,329 2,103 0,993 3,340 1,952 8,769 17,727 2,740 Min. 0,603 1,549 0,758 0,667 0,714 0,523 0,835 0,673 0,887 1,191 0,894 Median 1,254 2,663 3,794 0,770 1,078 0,784 1,408 1,313 1,510 1,806 1,344

Stock-Outs I 7 6 In 10 out of 11 participating DSOs stock-outs occured 5 4 3 2 1 0 CDC CBC CHAN JMS MEMS Koyom PCC MEDS BUFMAR CHAM CDMU

Way forward: > Filling the gaps > Moving prices further down, e.g.pooled procurment > Strengthening networking/information among DSOs and between DSOs < >facilities > Strenghtening DSOs by using them

Thank you for listening www. petersen.amh@difaem.de